Presentation of the attention-grabbing case of a affected person affected by castrate-resistant prostate most cancers (CRPC) with bone metastasis, who obtained concomitant treatment with abiraterone acetate (AA) and radium-223. The affected person skilled important scientific enchancment in his high quality of life and ache aid after starting the aforementioned treatment, with out being affected by opposed toxicities.
Currently, the appropriate choice of sufferers to obtain radium-223 treatment remains to be a scientific problem in the case of CRPC with metastasis. In this text, we talk about the future prospects of this treatment, reviewing present evidence about concomitant therapies with radium-223 and its current state, primarily based upon the current suggestions from the Pharmacovigilance Risk Assessment Committee (PRAC), and the knowledge offered in the ERA-223 examine.
Based on our scientific expertise, we offer sensible orientation for the integration of this radiopharmaceutical in the therapeutic plan for this group of sufferers. We conclude, regardless of some of the constructive outcomes and our wonderful expertise, that it will be clever to attend for the outcomes of the scientific trials which are finding out the security and advantages of the combined use of radium-223 with new hormone therapies.
Bearing in thoughts that to this point, the solely revealed large-scale randomised trial that investigated the mixture of AR-axis-targeted remedy with Ra-223 is unfavourable, the harms of the mixture outweighed any advantages in ERA-223. Nonetheless, with a purpose to advocate whether or not or not this treatment must be used, it’s important to outline the affected person profile that would profit from this therapeutic possibility.
Use and affect of the prehospital 12-lead ECG in the main PCI period (PHECG2): protocol for a mixed-method examine.
Use of the prehospital 12-lead ECG (PHECG) is really useful in sufferers presenting to emergency medical providers (EMS) with suspected acute coronary syndrome (ACS).
Prior analysis discovered that though PHECG use was related with improved 30-day survival, a 3rd of sufferers (usually girls, the aged and these with comorbidities) beneath EMS care didn’t obtain a PHECG.The general intention of the PHECG2 examine is to replace evidence on care and outcomes for sufferers eligible for PHECG, particularly addressing the following analysis questions: (1) Is there a distinction in 30-day mortality, and in reperfusion price, between those that do and those that don’t obtain PHECG? (2) Has the proportion of eligible sufferers who obtain PHECG modified since the introduction of main percutaneous coronary intervention networks? (3) Are sufferers that obtain PHECG totally different from these that don’t in phrases of social and demographic elements, or prehospital scientific presentation? (4) What elements affect EMS clinicians’ selections to carry out PHECG?This is an explanatory, mixed-method examine comprising 4 work packages (WPs). WP1 is a population-based, linked-data evaluation of a nationwide ACS registry (Myocardial Ischaemia National Audit Project). WP2 is a retrospective chart overview of affected person information from three giant regional EMS. WP3 contains focus teams of EMS personnel.
Nod1 antibody |
|||
| 22788-100ul | SAB | 100ul | 390 EUR |
NOD1 Antibody |
|||
| 25174-100ul | SAB | 100ul | 390 EUR |
NOD1 Antibody |
|||
| 32256-100ul | SAB | 100ul | 252 EUR |
NOD1 siRNA |
|||
| 20-abx926109 | Abbexa |
|
|
NOD1 siRNA |
|||
| 20-abx926110 | Abbexa |
|
|
NOD1 Antibody |
|||
| ABD6378 | Lifescience Market | 100 ug | 438 EUR |
NOD1 Antibody |
|||
| DF6378 | Affbiotech | 200ul | 304 EUR |
|
Description: NOD1 Antibody detects endogenous levels of total NOD1. |
|||
NOD1 Peptide |
|||
| 5947P | ProSci | 0.05 mg | 164.75 EUR |
|
Description: (CT) NOD1 peptide |
|||
NOD1 Peptide |
|||
| 42-460P | ProSci | 0.1 mg | 338 EUR |
|
Description: (CT) NOD1 Peptide |
|||
NOD1 antibody |
|||
| 70R-13231 | Fitzgerald | 100 ul | 457 EUR |
|
Description: Affinity purified Rabbit polyclonal NOD1 antibody |
|||
NOD1 Antibody |
|||
| 5947-002mg | ProSci | 0.02 mg | 171.82 EUR |
|
Description: NOD1 Antibody: NOD1 is a member of the NOD (nucleotide-binding oligomerization domain) family, a group of proteins that are involved in innate immune defense. NOD1 contains an N-terminal caspase recruitment domain (CARD), a centrally located nucleotide-binding domain (NBD), and ten tandem leucine-rich repeats (LRRs) in its C-terminus. The CARD is involved in apoptotic signaling, and NOD1 activates caspase-9 and NF-κB. LRRs participate in protein-protein interactions, and mutations in the NBD may affect the process of oligomerization and subsequent function of the LRR domain. This protein is an intracellular pattern-recognition receptor (PRR) that initiates inflammation in response to a subset of bacteria through the detection of bacterial diaminopimelic acid. |
|||
NOD1 Antibody |
|||
| 5947-01mg | ProSci | 0.1 mg | 436.42 EUR |
|
Description: NOD1 Antibody: NOD1 is a member of the NOD (nucleotide-binding oligomerization domain) family, a group of proteins that are involved in innate immune defense. NOD1 contains an N-terminal caspase recruitment domain (CARD), a centrally located nucleotide-binding domain (NBD), and ten tandem leucine-rich repeats (LRRs) in its C-terminus. The CARD is involved in apoptotic signaling, and NOD1 activates caspase-9 and NF-κB. LRRs participate in protein-protein interactions, and mutations in the NBD may affect the process of oligomerization and subsequent function of the LRR domain. This protein is an intracellular pattern-recognition receptor (PRR) that initiates inflammation in response to a subset of bacteria through the detection of bacterial diaminopimelic acid. |
|||
NOD1 cloning plasmid |
|||
| CSB-CL896866HU-10ug | Cusabio | 10ug | 233 EUR |
|
Description: A cloning plasmid for the NOD1 gene. |
|||
Anti-NOD1 antibody |
|||
| STJ24778 | St John's Laboratory | 100 µl | 277 EUR |
|
Description: This gene encodes a member of the NOD (nucleotide-binding oligomerization domain) family. This member is a cytosolic protein. It contains an N-terminal caspase recruitment domain (CARD), a centrally located nucleotide-binding domain (NBD), and 10 tandem leucine-rich repeats (LRRs) in its C terminus. The CARD is involved in apoptotic signaling, LRRs participate in protein-protein interactions, and mutations in the NBD may affect the process of oligomerization and subsequent function of the LRR domain. This protein is an intracellular pattern-recognition receptor (PRR) that initiates inflammation in response to a subset of bacteria through the detection of bacterial diaminopimelic acid. Multiple alternatively spliced transcript variants differring in the 5' UTR have been described, but the full-length nature of these variants has not been determined. |
|||
Polyclonal NOD1 Antibody |
|||
| APR03070G | Leading Biology | 0.05ml | 484 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD1 . This antibody is tested and proven to work in the following applications: |
|||
Polyclonal NOD1 Antibody |
|||
| APR06661G | Leading Biology | 0.1 mg | 659 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD1 . This antibody is tested and proven to work in the following applications: |
|||
NOD1 Rabbit pAb |
|||
| A1246-100ul | Abclonal | 100 ul | 308 EUR |
NOD1 Rabbit pAb |
|||
| A1246-200ul | Abclonal | 200 ul | 459 EUR |
NOD1 Rabbit pAb |
|||
| A1246-20ul | Abclonal | 20 ul | 183 EUR |
NOD1 Rabbit pAb |
|||
| A1246-50ul | Abclonal | 50 ul | 223 EUR |
Mouse Nod1 Antibody |
|||
| abx030859-400ul | Abbexa | 400 ul | 523 EUR |
Mouse Nod1 Antibody |
|||
| abx030859-80l | Abbexa | 80 µl | 286 EUR |
NOD1 Conjugated Antibody |
|||
| C32256 | SAB | 100ul | 397 EUR |
NOD1 Blocking Peptide |
|||
| DF6378-BP | Affbiotech | 1mg | 195 EUR |
pCMV-SPORT6-NOD1 |
|||
| PVT14153 | Lifescience Market | 2 ug | 495 EUR |
Anti-CARD4/NOD1 Antibody |
|||
| PB9294 | BosterBio | 100ug/vial | 334 EUR |
Mouse NOD1 shRNA Plasmid |
|||
| 20-abx979820 | Abbexa |
|
|
Human NOD1 shRNA Plasmid |
|||
| 20-abx957041 | Abbexa |
|
|
Anti-NOD1 / CARD4 antibody |
|||
| STJ70152 | St John's Laboratory | 100 µg | 359 EUR |
Human NOD1 ELISA KIT |
|||
| ELI-46124h | Lifescience Market | 96 Tests | 824 EUR |
Mouse Nod1 ELISA KIT |
|||
| ELI-35306m | Lifescience Market | 96 Tests | 865 EUR |
NOD1 ELISA KIT|Human |
|||
| EF005372 | Lifescience Market | 96 Tests | 689 EUR |
h NOD1 inducible lentiviral particles |
|||
| LVP751 | GenTarget | 1x107 IFU/ml x 200ul | 451 EUR |
|
Description: Pre-made over-expression lentivirus for expressing human target: h NOD1 (nucleotide-binding oligomerization domain containing 1), [alternative names: CARD4; CLR7.1; NLRC1]. The sub-cloned codon sequence is identical (100% match) to CDS region in NCBI ID: NM_006092. It also contains a RFP-Blasticidin dual selection marker. |
|||
Polyclonal NOD1 Antibody (C-Terminus) |
|||
| APR02775G | Leading Biology | 0.05mg | 484 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD1 (C-Terminus). This antibody is tested and proven to work in the following applications: |
|||
Polyclonal NOD1 Antibody (aa930-949) |
|||
| APR02826G | Leading Biology | 0.05ml | 484 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD1 (aa930-949). This antibody is tested and proven to work in the following applications: |
|||
Polyclonal NOD1 Antibody (C-term) |
|||
| APR03618G | Leading Biology | 0.1ml | 484 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD1 (C-term). This antibody is tested and proven to work in the following applications: |
|||
Polyclonal Mouse Nod1 Antibody (Center) |
|||
| APR04406G | Leading Biology | 0.1ml | 484 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Mouse Nod1 (Center). This antibody is tested and proven to work in the following applications: |
|||
NOD1 ELISA Kit (Human) (OKCA00743) |
|||
| OKCA00743 | Aviva Systems Biology | 96 Wells | 833 EUR |
|
Description: Description of target: Enhances caspase-9-mediated apoptosis. Induces NF-kappa-B activity via RIPK2 and IKK-gamma. Confers responsiveness to intracellular bacterial lipopolysaccharides (LPS). Forms an intracellular sensing system along with ARHGEF2 for the detection of microbial effectors during cell invasion by pathogens. Required for RHOA and RIPK2 dependent NF-kappa-B signaling pathway activation upon S.flexneri cell invasion. Involved not only in sensing peptidoglycan (PGN)-derived muropeptides but also in the activation of NF-kappa-B by Shigella effector proteins IpgB2 and OspB. Recruits NLRP10 to the cell membrane following bacterial infection.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 3.9 pg/mL |
|||
NOD1 ELISA Kit (Human) (OKEH08039) |
|||
| OKEH08039 | Aviva Systems Biology | 96 Wells | 896 EUR |
|
Description: Description of target: This gene encodes a member of the nucleotide-binding oligomerization domain (NOD)-like receptor (NLR) family of proteins. The encoded protein plays a role in innate immunity by acting as a pattern-recognition receptor (PRR) that binds bacterial peptidoglycans and initiates inflammation. This protein has also been implicated in the immune response to viral and parasitic infection. Major structural features of this protein include an N-terminal caspase recruitment domain (CARD), a centrally located nucleotide-binding domain (NBD), and 10 tandem leucine-rich repeats (LRRs) in its C terminus. The CARD is involved in apoptotic signaling, LRRs participate in protein-protein interactions, and mutations in the NBD may affect the process of oligomerization and subsequent function of the LRR domain. Mutations in this gene are associated with asthma, inflammatory bowel disease, Behcet disease and sarcoidosis in human patients.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.078 ng/mL |
|||
NOD1 ELISA Kit (Mouse) (OKEH08040) |
|||
| OKEH08040 | Aviva Systems Biology | 96 Wells | 1092 EUR |
|
Description: Description of target: ;Species reactivity: Mouse;Application: ELISA;Assay info: Assay Methodology: Quantitative Competitive ELISA;Sensitivity: 0.096ng/mL |
|||
Nod1 ORF Vector (Rat) (pORF) |
|||
| ORF071394 | ABM | 1.0 ug DNA | 506 EUR |
NOD1 ORF Vector (Human) (pORF) |
|||
| ORF007140 | ABM | 1.0 ug DNA | 95 EUR |
Nod1 ORF Vector (Mouse) (pORF) |
|||
| ORF051497 | ABM | 1.0 ug DNA | 506 EUR |
Nod1 ORF Vector (Mouse) (pORF) |
|||
| ORF051498 | ABM | 1.0 ug DNA | 506 EUR |
Polyclonal NOD1 / CARD4 Antibody (C-Term) |
|||
| APG00381G | Leading Biology | 0.1mg | 484 EUR |
|
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human NOD1 / CARD4 (C-Term). This antibody is tested and proven to work in the following applications: |
|||
NOD1 sgRNA CRISPR Lentivector set (Human) |
|||
| K1438501 | ABM | 3 x 1.0 ug | 339 EUR |
Nod1 sgRNA CRISPR Lentivector set (Rat) |
|||
| K6741701 | ABM | 3 x 1.0 ug | 339 EUR |
Nod1 sgRNA CRISPR Lentivector set (Mouse) |
|||
| K3911101 | ABM | 3 x 1.0 ug | 339 EUR |
NOD1 sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
| K1438502 | ABM | 1.0 ug DNA | 154 EUR |
NOD1 sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
| K1438503 | ABM | 1.0 ug DNA | 154 EUR |
NOD1 sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
| K1438504 | ABM | 1.0 ug DNA | 154 EUR |
Nod1 sgRNA CRISPR Lentivector (Rat) (Target 1) |
|||
| K6741702 | ABM | 1.0 ug DNA | 154 EUR |
Nod1 sgRNA CRISPR Lentivector (Rat) (Target 2) |
|||
| K6741703 | ABM | 1.0 ug DNA | 154 EUR |
Nod1 sgRNA CRISPR Lentivector (Rat) (Target 3) |
|||
| K6741704 | ABM | 1.0 ug DNA | 154 EUR |
NOD1 3'UTR GFP Stable Cell Line |
|||
| TU065800 | ABM | 1.0 ml | 1521 EUR |
Nod1 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|||
| K3911102 | ABM | 1.0 ug DNA | 154 EUR |
Nod1 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
| K3911103 | ABM | 1.0 ug DNA | 154 EUR |
Nod1 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|||
| K3911104 | ABM | 1.0 ug DNA | 154 EUR |
NOD1 Protein Vector (Human) (pPB-C-His) |
|||
| PV028557 | ABM | 500 ng | 329 EUR |
NOD1 Protein Vector (Human) (pPB-N-His) |
|||
| PV028558 | ABM | 500 ng | 329 EUR |
NOD1 Protein Vector (Human) (pPM-C-HA) |
|||
| PV028559 | ABM | 500 ng | 329 EUR |
NOD1 Protein Vector (Human) (pPM-C-His) |
|||
| PV028560 | ABM | 500 ng | 329 EUR |
NOD1 Protein Vector (Rat) (pPB-C-His) |
|||
| PV285574 | ABM | 500 ng | 1191 EUR |
NOD1 Protein Vector (Rat) (pPB-N-His) |
|||
| PV285575 | ABM | 500 ng | 1191 EUR |
NOD1 Protein Vector (Rat) (pPM-C-HA) |
|||
| PV285576 | ABM | 500 ng | 1191 EUR |
NOD1 Protein Vector (Rat) (pPM-C-His) |
|||
| PV285577 | ABM | 500 ng | 1191 EUR |
NOD1 Protein Vector (Mouse) (pPB-C-His) |
|||
| PV205986 | ABM | 500 ng | 1065 EUR |
NOD1 Protein Vector (Mouse) (pPB-N-His) |
|||
| PV205987 | ABM | 500 ng | 1065 EUR |
NOD1 Protein Vector (Mouse) (pPM-C-HA) |
|||
| PV205988 | ABM | 500 ng | 1065 EUR |
NOD1 Protein Vector (Mouse) (pPM-C-His) |
|||
| PV205989 | ABM | 500 ng | 1065 EUR |
NOD1 Protein Vector (Mouse) (pPB-C-His) |
|||
| PV205990 | ABM | 500 ng | 1065 EUR |
NOD1 Protein Vector (Mouse) (pPB-N-His) |
|||
| PV205991 | ABM | 500 ng | 1065 EUR |
NOD1 Protein Vector (Mouse) (pPM-C-HA) |
|||
| PV205992 | ABM | 500 ng | 1065 EUR |
NOD1 Protein Vector (Mouse) (pPM-C-His) |
|||
| PV205993 | ABM | 500 ng | 1065 EUR |
Nod1 3'UTR Luciferase Stable Cell Line |
|||
| TU214064 | ABM | 1.0 ml | Ask for price |
Nod1 3'UTR GFP Stable Cell Line |
|||
| TU264064 | ABM | 1.0 ml | Ask for price |
NOD1 3'UTR Luciferase Stable Cell Line |
|||
| TU015800 | ABM | 1.0 ml | 1521 EUR |
Nod1 3'UTR Luciferase Stable Cell Line |
|||
| TU114190 | ABM | 1.0 ml | Ask for price |
Nod1 3'UTR GFP Stable Cell Line |
|||
| TU164190 | ABM | 1.0 ml | Ask for price |
Nod1 ELISA Kit| Mouse Nucleotide-binding oligomerization domain |
|||
| EF015735 | Lifescience Market | 96 Tests | 689 EUR |
NOD1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV) |
|||
| LV645613 | ABM | 1.0 ug DNA | 1355 EUR |
NOD1 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV645617 | ABM | 1.0 ug DNA | 1355 EUR |
NOD1 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV645618 | ABM | 1.0 ug DNA | 1355 EUR |
Recombinant Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1) |
|||
| 4-RPK296Hu01 | Cloud-Clone |
|
|
|
Description: Recombinant Human Nucleotide Binding Oligomerization Domain Containing Protein 1 expressed in: E.coli |
|||
Nucleotide-Binding Oligomerization Domain-Containing Protein 1 (NOD1) Antibody |
|||
| abx117079-100ug | Abbexa | 100 ug | 467 EUR |
Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1) Antibody |
|||
| 20-abx104722 | Abbexa |
|
|
Nucleotide-Binding Oligomerization Domain-Containing Protein 1 (NOD1) Antibody |
|||
| abx038077-100ug | Abbexa | 100 ug | 391 EUR |
Nucleotide-Binding Oligomerization Domain-Containing Protein 1 (NOD1) Antibody |
|||
| 20-abx001158 | Abbexa |
|
|
Nucleotide-Binding Oligomerization Domain-Containing Protein 1 (NOD1) Antibody |
|||
| abx026454-400ul | Abbexa | 400 ul | 523 EUR |
Nucleotide-Binding Oligomerization Domain-Containing Protein 1 (NOD1) Antibody |
|||
| abx026454-80l | Abbexa | 80 µl | 286 EUR |
Nucleotide-Binding Oligomerization Domain-Containing Protein 1 (NOD1) Antibody |
|||
| abx430272-200ul | Abbexa | 200 ul | 384 EUR |
Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1) Antibody |
|||
| 20-abx212259 | Abbexa |
|
|
Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1) Antibody |
|||
| 20-abx212260 | Abbexa |
|
|
Human Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1) Protein |
|||
| 20-abx068373 | Abbexa |
|
|
NOD1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
|||
| K1438505 | ABM | 3 x 1.0 ug | 376 EUR |
Nod1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat) |
|||
| K6741705 | ABM | 3 x 1.0 ug | 376 EUR |
Nod1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
|||
| K3911105 | ABM | 3 x 1.0 ug | 376 EUR |
Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1) Polyclonal Antibody (Human) |
|||
| 4-PAK296Hu01 | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1) |
|||
Human Nucleotide-binding oligomerization domain-containing protein 1(NOD1) ELISA kit |
|||
| CSB-EL015914HU-24T | Cusabio | 1 plate of 24 wells | 165 EUR |
|
Description: Quantitativesandwich ELISA kit for measuring Human Nucleotide-binding oligomerization domain-containing protein 1 (NOD1) in samples from serum, plasma, tissue homogenates, cell lysates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
|||
Human Nucleotide-binding oligomerization domain-containing protein 1(NOD1) ELISA kit |
|||
| 1-CSB-EL015914HU | Cusabio |
|
|
|
Description: Quantitativesandwich ELISA kit for measuring Human Nucleotide-binding oligomerization domain-containing protein 1(NOD1) in samples from serum, plasma, tissue homogenates, cell lysates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
|||
Mouse Nod1/ Nucleotide-binding oligomerization domain-containing protein 1 ELISA Kit |
|||
| E1036Mo | Sunlong | 1 Kit | 632 EUR |
Human Nucleotide-Binding Oligomerization Domain-Containing Protein 1 (NOD1) ELISA Kit |
|||
| abx556317-96tests | Abbexa | 96 tests | 668 EUR |
Mouse Nucleotide-Binding Oligomerization Domain-Containing Protein 1 (NOD1) ELISA Kit |
|||
| abx555520-96tests | Abbexa | 96 tests | 739 EUR |
Human Nod1 (Apaf-1 like protein/CARD4) Control/blocking peptide #1 |
|||
| NOD11-P | Alpha Diagnostics | 100 ug | 164 EUR |
Rabbit Anti-Human Nod1 (Apaf-1 like protein/CARD4) antiserum #1 |
|||
| NOD11-S | Alpha Diagnostics | 100 ul | 457 EUR |
NOD1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
|||
| K1438506 | ABM | 1.0 ug DNA | 167 EUR |
NOD1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
|||
| K1438507 | ABM | 1.0 ug DNA | 167 EUR |
NOD1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
|||
| K1438508 | ABM | 1.0 ug DNA | 167 EUR |
NOD1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA) |
|||
| LV645614 | ABM | 1.0 ug DNA | 1355 EUR |
NOD1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro) |
|||
| LV645615 | ABM | 1.0 ug DNA | 1413 EUR |
NOD1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) |
|||
| LV645616 | ABM | 1.0 ug DNA | 1413 EUR |
Nod1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1) |
|||
| K6741706 | ABM | 1.0 ug DNA | 167 EUR |
Nod1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2) |
|||
| K6741707 | ABM | 1.0 ug DNA | 167 EUR |
Nod1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3) |
|||
| K6741708 | ABM | 1.0 ug DNA | 167 EUR |
Nod1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
|||
| K3911106 | ABM | 1.0 ug DNA | 167 EUR |
Nod1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
|||
| K3911107 | ABM | 1.0 ug DNA | 167 EUR |
Nod1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
|||
| K3911108 | ABM | 1.0 ug DNA | 167 EUR |
Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1) Polyclonal Antibody (Human), APC |
|||
| 4-PAK296Hu01-APC | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1). This antibody is labeled with APC. |
|||
Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1) Polyclonal Antibody (Human), Biotinylated |
|||
| 4-PAK296Hu01-Biotin | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1). This antibody is labeled with Biotin. |
|||
Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1) Polyclonal Antibody (Human), Cy3 |
|||
| 4-PAK296Hu01-Cy3 | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1). This antibody is labeled with Cy3. |
|||
Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1) Polyclonal Antibody (Human), FITC |
|||
| 4-PAK296Hu01-FITC | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1). This antibody is labeled with FITC. |
|||
Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1) Polyclonal Antibody (Human), HRP |
|||
| 4-PAK296Hu01-HRP | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1). This antibody is labeled with HRP. |
|||
Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1) Polyclonal Antibody (Human), PE |
|||
| 4-PAK296Hu01-PE | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1). This antibody is labeled with PE. |
|||
Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1) Polyclonal Antibody (Human), APC-Cy7 |
|||
| 4-PAK296Hu01-APC-Cy7 | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1). This antibody is labeled with APC-Cy7. |
|||
Rabbit Anti-Human Nod1 (Apaf-1 like protein/CARD4) IgG #1, aff pure |
|||
| NOD11-A | Alpha Diagnostics | 100 ug | 482 EUR |
WP4 will synthesise findings from WP1-Three to tell the growth of an intervention to extend PHECG uptake.The examine has been accepted by the London-Hampstead Research Ethics Committee (ref: 18LO1679). Findings shall be disseminated via suggestions to collaborating EMS, convention displays and publication in peer-reviewed journals.NCT03699137.